Differential role of IL-18 and IL-12 in the host defense against disseminated Candida albicans infection

European Journal of Immunology

Volumn 33, Issue 12, 2003, Pages 3409-3417

  Netea, Mihai G ^a   Vonk, Alieke G ^a   van den Hoven, Mabel ^a   Verschueren, Ineke ^a   Joosten, Leo A ^a   van Krieken, Johan H ^a   van den Berg, Wim B ^a   Van der Meer, Jos W M ^a   Kullberg, Bart Jan ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Candida albicans; Chemokines; IFN ; IL 12; IL 18

Indexed keywords

CHEMOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; MACROPHAGE INFLAMMATORY PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; HISTOPATHOLOGY; HOST RESISTANCE; IMMUNOLOGICAL PARAMETERS; IMMUNOMODULATION; INTRACELLULAR KILLING; KNOCKOUT MOUSE; MONOCYTE; MORTALITY; MOUSE; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; TH1 CELL;

ANIMALS; CANDIDIASIS; CYTOKINES; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-18; MICE; MICE, INBRED C57BL; MONOCYTES; NEUTROPHILS; PHAGOCYTOSIS;

EID: 0346121470     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200323737     Document Type: Article

References (34)

1. Blumberg, H. M., Jarvis, W. R., Soucie, J. M. at al., Risk factors for candidal bloodstream infections in surgical intensive care patients: the NEMIS prospective multicenter study. Clin. Infect. Dis. 2001. 33: 177-186.
2. Kullberg, B. J., Van 't Wout, J. W., Hoogstraten, C. and Van Furth, R., Recombinant interferon-γ enhances resistance to acute disseminated Candida albicans infection in mice. J. Infect. Dis. 1993. 168: 436-443.
3. Djeu, J. Y., Blanchard, D. K., Halkias, D. and Friedman, H., Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-γ and tumor necrosis factor. J. Immunol. 1986. 137:2980-2984.
4. Marodi, L., Schreiber, S., Anderson, D. C., MacDermott, R. P., Korchak, H. M. and Johnston, R. B. Jr., Enhancement of macrophage candidacidal activity by interferon-γ. Increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors. J. Clin. Invest. 1993. 91:2596-2601.
5. Balish, E., Wagner, R. D., Vasquez-Torres, A., Pierson, C. and Warner, T., Candidiasis in interferon-gamma knock-out (IFN - gamma-/-) mice. J. Infect. Dis. 1998. 178:478-487.
6. Lavigne, L. M., Schopf, L. R., Chung, C. L., Maylor, R. and Sypek, J. P., The role of recombinant IL-12 and IFN-gamma in the pathogenesis of a murine Candida albicans infection. J. Immunol. 1998. 160:284-292.
7. Scott, P., IL-12: initiation cytokine for cell-mediated immunity. Science. 1993. 260:496-497.
8. Okamura, H., Nagata, K., Komatsu, T. at al., A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock. Infect. Immun. 1995. 63:3966-3972.
9. Fantuzzi, G., Reed, D. A. and Dinarello, C. A., IL-12-induced IFN-gamma is dependent on caspase-1 processing of the IL-18 precursor. J. Clin. Invest. 1999. 104: 761-767.
10. Netea, M. G., Stuyt, R. J., Kim, S. H., Van der Meer, J. W. M., Kullberg, B. J. and Dinarello, C. A., The role of endogenous interleukin (IL)-18, IL-12, IL-1beta, and tumor necrosis factor-alpha in the production of interferon-gamma induced by Candida albicans in human whole-blood cultures. J. Infect. Dis. 2002. 185: 963-970.
11. Stuyt, R. J., Netea, M. G., Verschueren, I. et al., Role of interleukin-18 in host defense against disseminated Candida albicans infection. Infect. Immun. 2002. 70: 3284-3286.
12. Mencacci, A., Cenci, E., Del Sero, G. at al., IL-10 is required for development of protective Th1 responses in IL-12-deficient mice upon Candida albicans infection. J. Immunol. 1998. 161: 6228-6237.
13. Lauw, F. N., Branger, J., Florquin, S. at al., IL-18 improves the early antimicrobial response to pneumococcal pneumonia. J. Immunol. 2002. 168: 372-378.
14. Kinjo, Y., Kawakami, K., Uezu, K. at al., Contribution of IL-18 to Th1 response and host defense against infection by Mycobacterium tuberculosis: a comparative study with IL-12p40. J. Immunol. 2002. 169: 323-329.
15. Kawakami, K., Qureshi, M. H., Zhang, T., Okamura, H., Kurimoto, H. and Saito, A., IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-gamma production. J. Immunol. 1997. 159: 5528-5534.
16. Mastroeni, P., Clare, S., Khan, S. at al., Interleukin 18 contributes to host resistance and gamma interferon production in mice infected with virulent Salmonella typhimurium. Infect. Immun. 1999. 67: 478-483.
17. Cai, G., Kastelein, R., Hunter, C. A., Interleukin-18 (IL-18) enhances innate IL-12-mediated resistance to Toxoplasma gondii. Infect. Immun. 2000. 68: 6932-6938.
18. Huang, X., McClellan, S. A., Barrett, R. P. and Hazlett, L. D., IL-18 contributes to host resistance against infection with Pseudomonas aeruginosa through induction of IFN-gamma production. J. Immunol. 2002. 168: 5756-5763.
19. Ferrante, A., Tumor necrosis factor alpha potentiates neutrophil antimicrobial activity: Increased fungal activity against Torulopsis glabrata and Candida albicans and associated increases in oxigen radical production and lysosomal enzyme release. Infect. Immun. 1989. 57: 2115-2122.
20. Fang, F. C., Mechanisms of nitric oxide-related antimicrobial activity. J. Clin. Invest. 1997. 12: 2818-2825.
21. Pure, A. J., Fantuzzi, G., Gu, Y., Ps, M. S.-S. and Dinarello, C. A., Interleukin-18 (IFN-γ inducing factor) induces IL-8 and IL-1β via TNFα production from non-CD14+ human mononuclear cells. J. Clin. Invest. 1998. 101: 711-721.
22. Netea, M. G., Kullberg, B. J., Verschueren, I. and Van der Meer, J. W. M., Interleukin-18 induces production of proinflammatory cytokines in mice: no intermediate role for the cytokines of the tumor necrosis factor family and interleukin-1beta. Eur. J. Immunol. 2000. 30: 3057-3060.
23. Kohka, H., Yoshino, T., Iwagaki, H. et al., Interleukin-18/ interferon-gamma-inducing factor, a novel cytokine, up-regulates ICAM-1 (CD54) expression in KG-1 cells. J. Leuk. Biol. 1998. 64: 519-527.
24. Netea, M. G., Fantuzzi, G., Kullberg, B. J. et al., Neutralization of interleukin-18 reduces neutrophil tissue accumulation and protects mice against lethal Escherichia coli and Salmonella typhimurium endotoxemia. J. Immunol. 2000. 164: 2644-2649.
25. Joosten, L. A., van de Loo, F. A., Lubberts, E. et al., An IFN-gamma-independent proinflammatory role of IL-18 in murine streptococcal cell wall arthritis. J. Immunol. 2000. 165: 6553-6558.
26. Takeda, K., Tsutsui, H., Yoshimoto, T. et al., Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity. 1998. 8: 383-390.
27. Magram, J., Connaughton, S. E., Warrier, R. R. et al., Interleukin-12-deficient mice are defective in IFN- gamma production and type 1 cytokine responses. Immunity. 1996. 4: 471-481.
28. Lehrer, R. I. and Cline, M. J., Interactions of Candida albicans with human leukocytes and serum. J. Bacteriol. 1969. 98: 996-1004.
29. Kullberg, B. J., Van 't Wout, J. W. and Van Furth, R., Role of granulocytes in enhanced host resistance to Candida albicans induced by recombinant interleukin-1. Infect. Immun. 1990. 58: 3319-3324.
30. Netea, M. G., Demacker, P. N. M., Kullberg, B. J. et al., Low-density-lipoprotein receptor deficient mice are protected against lethal endotoxinemia and severe Gram-negative infections. J. Clin. Invest. 1996. 97: 1366-1372.
31. Gaviria, J. M., van Burik, J. A., Dale, D. C., Root, R. K. and Liles, W. C., Modulation of neutrophil-mediated activity against the pseudo-hyphal form of Candida albicans by granulocyte colony-stimulating factor (G-CSF) administered in vivo. J. Infect. Dis. 1999. 179: 1301-1304.
32. Vonk, A. G., Wieland, C. W., Netea, M. G. and Kullberg, B. J., Phagocytosis and intracellular killing of Candida albicans blastoconidia by neutrophils and macrophages: a comparison of different microbiological test systems. J. Microbiol. Methods. 2002. 49: 55-62.
33. Lundqvist, H. and Dahlgren, C., Isoluminol-enhanced chemiluminescence: a sensitive method to study the release of superoxide anion from human neutrophils. Free Radical Biol. 1996. 20: 785-792.
34. Ding, A. H., Nathan, C. F. and Stuehr, D. J., Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. J. Immunol. 1988. 141: 2407-2412.